Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes

NCT00174681 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine

Sponsor

Sanofi